Turns out that GLP-1 drugs aren’t just slimming waistlines — they’re shrinking tumors, too. A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors ...

In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant weight loss in obese mice but also slashed breast cancer tumor growth. The ...

A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors.

Anti-diabetic and obesity drug, tirzepatide, also known as Mounjaro and Zepbound, induced weight loss in obese mice and reduced growth of breast cancer tumors. The corresponding study was presented at ...

In the world of cancer treatment, success stories are often hard to come by. But for patients battling advanced head and neck cancers, especially those whose tumors have outwitted chemotherapy and ...

Hua-Ying Fan, PhD, hopes that her team's latest discovery could help the almost 21,000 people who are expected to receive an ovarian cancer diagnosis this year. Fan's team at The University of New ...